← All stocks

ARTIVION, INC.

AORT Net selling
CIK 0000784199 #2312 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$20.73M
$0.00 on a plan · $8.15M straight out of an exercise
Sold at will
$12.58M
48 of 64 sales
Net
−$20.73M
−$12.58M against sales at will

By person

15 insiders · 64 transactions
26.2×

J. Patrick Mackin holds 26.2 times base salary in stock. $21.91M of shares against $835.15K in salary for 2025.

Salary from the company's own proxy. The shares are what J. Patrick Mackin last reported holding, valued at $24.97, the price Common Stock was last bought or sold at on the open market here, on 10 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Mackin James P
President & CEO
$9.72M (9)
−$9.72M
877,275
1.80%
$21.91M
+24.3%
Stanton Marshall S.
SVP, Clinical & MD Affair
$3.43M (13) scheduled
−$3.43M
60,097
0.1233%
$1.50M
−29.6%
Holloway Jean F
SVP, General Counsel
$2.54M (13)
−$2.54M
184,118
0.3776%
$4.60M
+12.2%
Davis John E
Chief Commercial Officer
$1.75M (9)
−$1.75M
230,794
0.4734%
$5.76M
+37.4%
GREEN ANDREW M
SVP, Regulatory and Quality
$1.43M (6) scheduled
−$1.43M
40,160
0.0824%
$1.00M
−40.8%
Horton Amy
VP, Chief Accounting Officer
$870.06K (8)
−$870.06K
139,088
0.2853%
$3.47M
−0.6%
Berry Lance A
EVP, COO, CFO & Treasurer
$803.21K (5)
−$803.21K
210,112
0.4309%
$5.25M
+165.7%
Hoff Elizabeth A
Director
$189.41K (1)
−$189.41K
34,765
0.0713%
$868.08K
+38.7%
BEVEVINO DANIEL J
Director
157,637
0.3233%
$3.94M
+9.7%
ACKERMAN THOMAS F
Director
157,472
0.3230%
$3.93M
+9.7%
Salveson Jon W
Director
137,416
0.2818%
$3.43M
+11.3%
Bullock James
Director
76,223
0.1563%
$1.90M
+22.3%
Burbank Jeffrey H
Director
61,372
0.1259%
$1.53M
+29.3%
Borgstrom Marna P
Director
56,938
0.1168%
$1.42M
+33.1%
SEMEDO ANTHONY B.
Director
46,960
0.0963%
$1.17M
+39.9%
Insider
Date
Role
Action
Shares
Price
Amount
GREEN ANDREW M
10 Sep 2026
SVP, Regulatory and Quality
Sell
11,480
$24.97
$286.66K
GREEN ANDREW M
3 Sep 2026
SVP, Regulatory and Quality
Sell
1,493
$26.02
$38.84K
GREEN ANDREW M
2 Sep 2026
SVP, Regulatory and Quality
Sell
6,510
$27.27
$177.50K
Mackin James P
19 Aug 2026
President & CEO
Sell
70,000
$28.96
$2.03M
Berry Lance A
14 Aug 2026
EVP, COO, CFO & Treasurer
Sell
715
$28.55
$20.41K
GREEN ANDREW M
14 Aug 2026
SVP, Regulatory and Quality
Sell
616
$28.55
$17.59K
Holloway Jean F
12 Aug 2026
SVP, General Counsel
Sell
977
$28.49
$27.83K
GREEN ANDREW M
11 Jun 2026
SVP, Regulatory and Quality
Sold after exercise
30,000
$20.69
$620.82K
GREEN ANDREW M
11 Jun 2026
SVP, Regulatory and Quality
Sold after exercise
14,001
$20.71
$289.92K
Holloway Jean F
4 Mar 2026
SVP, General Counsel
Sell
8,962
$38.00
$340.56K
Mackin James P
3 Mar 2026
President & CEO
Sell
17,887
$37.78
$675.69K
Berry Lance A
3 Mar 2026
EVP, COO, CFO & Treasurer
Sell
6,316
$37.78
$238.59K
Davis John E
3 Mar 2026
Chief Commercial Officer
Sell
4,573
$37.78
$172.75K
Stanton Marshall S.
3 Mar 2026
SVP, Clinical & MD Affair
Sell
2,149
$37.78
$81.18K
Holloway Jean F
3 Mar 2026
SVP, General Counsel
Sell
3,843
$37.78
$145.17K
Horton Amy
3 Mar 2026
VP, Chief Accounting Officer
Sell
901
$37.78
$34.04K
Davis John E
2 Mar 2026
Chief Commercial Officer
Sell
2,784
$38.02
$105.86K
Berry Lance A
2 Mar 2026
EVP, COO, CFO & Treasurer
Sell
5,178
$38.02
$196.89K
Holloway Jean F
2 Mar 2026
SVP, General Counsel
Sell
2,183
$38.02
$83.01K
Mackin James P
2 Mar 2026
President & CEO
Sell
14,911
$38.02
$566.99K
Stanton Marshall S.
2 Mar 2026
SVP, Clinical & MD Affair
Sell
1,513
$38.02
$57.53K
Horton Amy
2 Mar 2026
VP, Chief Accounting Officer
Sell
641
$38.02
$24.37K
Davis John E
24 Feb 2026
Chief Commercial Officer
Sell
2,075
$35.69
$74.06K
Berry Lance A
24 Feb 2026
EVP, COO, CFO & Treasurer
Sell
4,485
$35.69
$160.08K
Mackin James P
24 Feb 2026
President & CEO
Sell
13,936
$35.69
$497.42K
Holloway Jean F
24 Feb 2026
SVP, General Counsel
Sell
1,668
$35.69
$59.54K
Stanton Marshall S.
24 Feb 2026
SVP, Clinical & MD Affair
Sell
1,259
$35.69
$44.94K
Horton Amy
24 Feb 2026
VP, Chief Accounting Officer
Sell
830
$35.69
$29.63K
Davis John E
23 Feb 2026
Chief Commercial Officer
Sell
3,773
$37.59
$141.82K
Berry Lance A
23 Feb 2026
EVP, COO, CFO & Treasurer
Sell
4,981
$37.59
$187.23K
Mackin James P
23 Feb 2026
President & CEO
Sell
20,962
$37.59
$787.92K
Holloway Jean F
23 Feb 2026
SVP, General Counsel
Sell
3,079
$37.59
$115.73K
Stanton Marshall S.
23 Feb 2026
SVP, Clinical & MD Affair
Sell
2,423
$37.59
$91.08K
Horton Amy
23 Feb 2026
VP, Chief Accounting Officer
Sell
1,731
$37.59
$65.06K
Davis John E
15 Dec 2025
Chief Commercial Officer
Sell
5,000
$45.11
$225.55K
Horton Amy
8 Dec 2025
VP, Chief Accounting Officer
Sell
4,572
$44.42
$203.08K
Holloway Jean F
3 Dec 2025
SVP, General Counsel
Sell
5,267
$45.30
$238.60K
Holloway Jean F
3 Dec 2025
SVP, General Counsel
Sell
2,048
$45.30
$92.77K
Mackin James P
3 Dec 2025
President & CEO
Sold after exercise
30,921
$45.46
$1.41M
Mackin James P
2 Dec 2025
President & CEO
Sold after exercise
30,921
$45.56
$1.41M
Stanton Marshall S.
21 Nov 2025
SVP, Clinical & MD Affair
Sold after exercise
8,370
$45.35
$379.54K
Stanton Marshall S.
21 Nov 2025
SVP, Clinical & MD Affair
Sold after exercise
18,705
$44.91
$840.04K
Stanton Marshall S.
21 Nov 2025
SVP, Clinical & MD Affair
Sold after exercise
5,715
$45.35
$259.15K
Stanton Marshall S.
21 Nov 2025
SVP, Clinical & MD Affair
Sold after exercise
14,586
$44.92
$655.19K
Stanton Marshall S.
20 Nov 2025
SVP, Clinical & MD Affair
Sold after exercise
1,355
$44.28
$60.00K
Stanton Marshall S.
20 Nov 2025
SVP, Clinical & MD Affair
Sold after exercise
2,033
$44.32
$90.09K
Stanton Marshall S.
20 Nov 2025
SVP, Clinical & MD Affair
Sold after exercise
11,888
$44.14
$524.74K
Hoff Elizabeth A
18 Nov 2025
Director
Sell
4,200
$45.10
$189.41K
Horton Amy
17 Nov 2025
VP, Chief Accounting Officer
Sell
6,000
$45.73
$274.38K
Davis John E
17 Nov 2025
Chief Commercial Officer
Sold after exercise
6,394
$45.17
$288.82K
Holloway Jean F
17 Nov 2025
SVP, General Counsel
Sold after exercise
6,394
$45.17
$288.82K
Davis John E
14 Nov 2025
Chief Commercial Officer
Sold after exercise
6,393
$44.67
$285.58K
Holloway Jean F
14 Nov 2025
SVP, General Counsel
Sold after exercise
6,393
$45.00
$287.69K
Stanton Marshall S.
13 Nov 2025
SVP, Clinical & MD Affair
Sell
4,993
$45.86
$228.97K
Holloway Jean F
13 Nov 2025
SVP, General Counsel
Sell
5,761
$45.86
$264.19K
Mackin James P
13 Nov 2025
President & CEO
Sell
34,210
$45.86
$1.57M
Davis John E
13 Nov 2025
Chief Commercial Officer
Sell
6,563
$45.86
$300.97K
Horton Amy
13 Nov 2025
VP, Chief Accounting Officer
Sell
3,482
$45.86
$159.68K
Holloway Jean F
11 Nov 2025
SVP, General Counsel
Sold after exercise
10,000
$46.18
$461.80K
Stanton Marshall S.
10 Nov 2025
SVP, Clinical & MD Affair
Sell
2,566
$44.62
$114.49K
Horton Amy
10 Nov 2025
VP, Chief Accounting Officer
Sell
1,789
$44.62
$79.82K
Davis John E
10 Nov 2025
Chief Commercial Officer
Sell
3,373
$44.62
$150.50K
Mackin James P
10 Nov 2025
President & CEO
Sell
17,580
$44.62
$784.40K
Holloway Jean F
10 Nov 2025
SVP, General Counsel
Sell
2,960
$44.62
$132.07K

What was left out

Form 4 filings counted 56
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 16
Sales at will 48
Transactions with no price 0
Shares from compensation/vesting 690,931
History held since 13 Sep 2016